Expertise in
3
conditions

Ning-sheng Lai

Hualien City, TNQ, TW 
Expertise in
3
conditions
Hualien City, TNQ, TW 

Overview

Ning-sheng Lai practices practicing medicine in Hualien City, Taiwan.

Lai is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Ankylosing Spondylitis, and Systemic Lupus Erythematosus (SLE).

They are actively involved in clinical research, co-authoring 83 peer reviewed articles and participating in 2 clinical trials.

Locations

Hualien City, TNQ 97037, Taiwan
Other Locations
Dalin, KHQ, Taiwan
Min Sheng Rd, Minsheng, KHQ 62247, Taiwan
Jiayi Shi, TNQ 62247, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

83 Total Publications

Workflow-embedded automation improves hepatitis B screening and safety in b/tsDMARD users.
Workflow-embedded automation improves hepatitis B screening and safety in b/tsDMARD users.
Journal: BMC infectious diseases
Published: February 21, 2026

Frequently Asked Questions about Ning-sheng Lai

Is Ning-sheng Lai a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Ning-sheng Lai is classified as an Advanced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ning-sheng Lai participate in research or clinical trials?

Yes. Ning-sheng Lai has published 83 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Ning-sheng Lai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lai's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile